, a bio/informatics shared resource is still "open for business" - Visit the CDS website

James Crowe
Faculty Member
Last active: 3/31/2019

  1. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope. Long F, Doyle M, Fernandez E, Miller AS, Klose T, Sevvana M, Bryan A, Davidson E, Doranz BJ, Kuhn RJ, Diamond MS, Crowe JE, Rossmann MG (2019) Proc Natl Acad Sci U S A 116(5): 1591-1596
    › Primary publication · 30642974 (PubMed) · PMC6358714 (PubMed Central)
  2. Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein. Kim AS, Austin SK, Gardner CL, Zuiani A, Reed DS, Trobaugh DW, Sun C, Basore K, Williamson LE, Crowe JE, Slifka MK, Fremont DH, Klimstra WB, Diamond MS (2019) Nat Microbiol 4(1): 187-197
    › Primary publication · 30455470 (PubMed) · PMC6294662 (PubMed Central)
  3. Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains. Turner HL, Pallesen J, Lang S, Bangaru S, Urata S, Li S, Cottrell CA, Bowman CA, Crowe JE, Wilson IA, Ward AB (2019) PLoS Biol 17(2): e3000139
    › Primary publication · 30716060 (PubMed) · PMC6375650 (PubMed Central)
  4. New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications. Engelhardt BG, Savani U, Jung DK, Powers AC, Jagasia M, Chen H, Winnick JJ, Tamboli RA, Crowe JE, Abumrad NN (2019) Biol Blood Marrow Transplant 25(6): 1225-1231
    › Primary publication · 30738170 (PubMed) · PMC6559863 (PubMed Central)
  5. Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses. Sevy AM, Wu NC, Gilchuk IM, Parrish EH, Burger S, Yousif D, Nagel MBM, Schey KL, Wilson IA, Crowe JE, Meiler J (2019) Proc Natl Acad Sci U S A 116(5): 1597-1602
    › Primary publication · 30642961 (PubMed) · PMC6358683 (PubMed Central)
  6. Mechanism of Enhanced Immature Dengue Virus Attachment to Endosomal Membrane Induced by prM Antibody. Wirawan M, Fibriansah G, Marzinek JK, Lim XX, Ng TS, Sim AYL, Zhang Q, Kostyuchenko VA, Shi J, Smith SA, Verma CS, Anand G, Crowe JE, Bond PJ, Lok SM (2019) Structure 27(2): 253-267.e8
    › Primary publication · 30471923 (PubMed) · PMC6365167 (PubMed Central)
  7. Influenza Virus-Specific Human Antibody Repertoire Studies. Crowe JE (2019) J Immunol 202(2): 368-373
    › Primary publication · 30617118 (PubMed) · PMC6327975 (PubMed Central)
  8. Human mAbs to Staphylococcus aureus IsdA Provide Protection Through Both Heme-Blocking and Fc-Mediated Mechanisms. Bennett MR, Bombardi RG, Kose N, Parrish EH, Nagel MB, Petit RA, Read TD, Schey KL, Thomsen IP, Skaar EP, Crowe JE (2019) J Infect Dis 219(8): 1264-1273
    › Primary publication · 30496483 (PubMed) · PMC6452300 (PubMed Central)
  9. High frequency of shared clonotypes in human B cell receptor repertoires. Soto C, Bombardi RG, Branchizio A, Kose N, Matta P, Sevy AM, Sinkovits RS, Gilchuk P, Finn JA, Crowe JE (2019) Nature 566(7744): 398-402
    › Primary publication · 30760926 (PubMed) · PMC6949180 (PubMed Central)
  10. Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection. Williamson LE, Flyak AI, Kose N, Bombardi R, Branchizio A, Reddy S, Davidson E, Doranz BJ, Fusco ML, Saphire EO, Halfmann PJ, Kawaoka Y, Piper AE, Glass PJ, Crowe JE (2019) J Virol 93(8)
    › Primary publication · 30728263 (PubMed) · PMC6450119 (PubMed Central)